BALAXI PHARMACEUTICALS
Back to Income Statement
|
BALAXI PHARMACEUTICALS Last 5 Year Earnings Per Share (EPS) History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Adjusted EPS | ₹-1.34 | ₹10.16 | ₹9.64 | ₹7.45 | ₹1.23 |
What is the latest Earnings Per Share (EPS) of BALAXI PHARMACEUTICALS ?
| Year | Earnings Per Share (EPS) |
|---|---|
| Mar2025 | ₹-1.34 |
| Mar2024 | ₹10.16 |
| Mar2023 | ₹9.64 |
| Mar2022 | ₹7.45 |
| Mar2021 | ₹1.23 |
How is Earnings Per Share (EPS) of BALAXI PHARMACEUTICALS Trending?
| Years | Earnings Per Share (EPS) | % Change | |
|---|---|---|---|
| Mar2025 | ₹-1.34 | Negative | |
| Mar2024 | ₹10.16 | 5.39 | |
| Mar2023 | ₹9.64 | 29.40 | |
| Mar2022 | ₹7.45 | 505.69 | |
| Mar2021 | ₹1.23 | - | |
Compare Earnings Per Share (EPS) of peers of BALAXI PHARMACEUTICALS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| BALAXI PHARMACEUTICALS | ₹127.1 Cr | -5.7% | -16.7% | -64.7% | Stock Analytics | |
| ADANI ENTERPRISES | ₹289,089.0 Cr | 15.2% | -1% | 0.4% | Stock Analytics | |
| REDINGTON | ₹20,892.9 Cr | 0.3% | -6.4% | 36.7% | Stock Analytics | |
| MMTC | ₹9,483.0 Cr | 0.3% | -5.4% | -6.3% | Stock Analytics | |
| LLOYDS ENTERPRISES | ₹9,466.2 Cr | 10.7% | -6.2% | 23.3% | Stock Analytics | |
| HONASA CONSUMER | ₹9,149.4 Cr | 1.4% | -6.3% | 25.8% | Stock Analytics | |
BALAXI PHARMACEUTICALS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| BALAXI PHARMACEUTICALS | -5.7% |
-16.7% |
-64.7% |
| SENSEX | 1.3% |
-2.5% |
8.5% |
You may also like the below Video Courses